Lv21
154 积分 2024-01-11 加入
Formononetin Mitigates Liver Fibrosis via Promoting Hepatic Stellate Cell Senescence and Inhibiting EZH2/YAP Axis
2小时前
待确认
A researcher’s guide to preclinical mouse NASH models
1个月前
已完结
JAK inhibitor selectivity: new opportunities, better drugs?
2个月前
已完结
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
2个月前
已完结
Antioxidative Hyaluronic Acid–Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy
3个月前
已完结
Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11
3个月前
已完结
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH
3个月前
已完结
The deacetylase SIRT2 contributes to autoimmune disease pathogenesis by modulating IL-17A and IL-2 transcription
3个月前
已完结
New and emerging treatments for metabolic dysfunction-associated steatohepatitis
4个月前
已完结
TM7SF3 controls TEAD1 splicing to prevent MASH-induced liver fibrosis
6个月前
已完结
皖公网安备34019202002308
